Primary study · included by 2 reviews

Neoadjuvant immunoradiotherapy in patients with locally advanced oral cavity squamous cell carcinoma: a retrospective study.

Shen 2022 · Shen Peng, Qiao Bo, Jin Nenghao, et al. · Investigational new drugs · 2022

Included by

Two-year follow-up outcomes of neoadjuvant therapy in oral squamous cell carcinoma: an exploratory systematic review and meta-analysis.

Non-Cochrane · prognostic · 2026 · cited as Shen 2022 · Reference list 25-34; Table 1; Fig 4-8

The review does not say which of its outcomes this study informs.

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.

Non-Cochrane · intervention · 2026 · cited as Shen 2022 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

2 including reviews in total.